Open Clinical Trials:
CLINICAL TRIAL 19694
Phase II Study of Nivolumab and Ramucirumab for Patients with Previously-Treated Mesothelioma
Disease Site: Mesothelioma, Lung
View Trial DetailsCLINICAL TRIAL 20936
DuRvalumab (MEDI4736) with ChEmotherapy as First Line TreAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
Disease Site: Lung, Mesothelioma
View Trial Details